scispace - formally typeset
P

Pengping Li

Researcher at Nanjing Medical University

Publications -  13
Citations -  1376

Pengping Li is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 4, co-authored 10 publications receiving 855 citations.

Papers
More filters
Journal ArticleDOI

High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis

TL;DR: During treatment, lung cancer survivors infected with severe acute respiratory syndrome coronavirus 2 had a shorter median time from symptom onset to hospitalization and longer clinical symptom remission time than non-cancer individuals.
Journal ArticleDOI

Implications of cardiac markers in risk-stratification and management for COVID-19 patients.

TL;DR: COVID-19 patients with pre-existing coronary artery disease represented a higher abnormal percentage of cardiac markers, accompanied by high mortality and ICU admission rate, and brain natriuretic peptide is an effective biomarker for risk assessment in COVID- 19 patients with or without pre- existing CAD.
Journal ArticleDOI

miRNA Mediated Noise Making of 3'UTR Mutations in Cancer.

TL;DR: The findings elucidate a complex relationship between miRNA, mRNA, and mutations, and suggest that 3′UTR mutations may play an important role in tumor development.